Ocular immune privilege: therapeutic opportunities from an experiment of nature
The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the vitreous space, there are higher chances of exposure to systemic circulation,15 whereas the subretinal space does not expose AAV to systemic circulation, owing to the blood-retina barrier.9,33”
From Systemic and local immune responses to intraocular AAV vector administration in non-human primates (2022) · cites this paper as [9]
In the citing paper
“Idebenone (Raxone), a synthetic analogue of coenzyme Q10, has been used by practitioners in the European Union albeit with controversial efficacy, because results from a phase 3 study were not statistically different from placebo.11”
In the citing paper
“The eye was historically considered to be an immune privileged site, as a result of several features. These include the blood-retinal barrier formed by tight junctions between endothelial and retinal pigmented epithelium cells as well as in retinal vessels, the lack of anatomically defined lymphatic drainage and an intraocular anti-inflammatory and immunomodulatory micro-environment [43].”
From Characterization of anti-AAV2 neutralizing antibody levels in sheep prior to and following intravitreal AAV2.7m8 injection (2024) · cites this paper as [43]
In the citing paper
“Additionally, there are lower risks of immunogenicity when targeting AAV vectors towards relatively immune-privileged sites, such as the subretinal space and the cochlea [93,94].”
From Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders (2022) · cites this paper as [93]
Citations
Cites
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 2,005 · cited 1×
“CD95L, which is expressed constitutively by cells of the eye (and other immune-privileged tissues), is partially responsible for acceptance of orthotopic corneal allografts, and for making the cornea and retinal pigment epithelium immune-privileged tissue”
BackgroundMedawar, P. B. (1948) · PubMed · Cited by 1,109
Immunologically Privileged Sites
Barker, C. F., & Billingham, R. E. (1978) · Advances in Immunology · doi:10.1016/s0065-2776(08)60930-x · Cited by 815
PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2
Carter, L. L., Fouser, L. A., Jussif, J., Fitz, L., Deng, B., Wood, C. R., Collins, M., Honjo, T., Freeman, G. J., & Carreno, B. M. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200203)32:3<634::aid-immu634>3.0.co;2-9 · Cited by 673
Immunobiology of Tissue Transplantation: A Return to the Passenger Leukocyte Concept
Laffery, K. J., Prowse, S. J., Simeonovic, C. J., & Warren, H. S. (1983) · Annual Review of Immunology · doi:10.1146/annurev.iy.01.040183.001043 · Cited by 509
Suda, T., Hashimoto, H., Tanaka, M., Ochi, T., & Nagata, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.2045 · Cited by 508 · cited 1×
“Attempts to achieve this goal with CD95L have already been made and the results are mixe”
ResultIdentification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor.
Cousins, S. W., McCabe, M. M., Danielpour, D., & Streilein, J. W. (1991) · PubMed · Cited by 477
Self-citationKang, S.-M., Schneider, D. B., Lin, Z., Hanahan, D., Dichek, D. A., Stock, P. G., & Baekkeskov, S. (1997) · Nature Medicine · doi:10.1038/nm0797-738 · Cited by 450 · cited 1×
“First, conventional immune-recognition pathways can be interrupted by providing allografts with healthy corneal epithelium, or factors derived from this tissue that suppress lymphangiogenesis and attendant inflammatio”
BackgroundSo, K.-F., & Aguayo, A. J. (1985) · Brain Research · doi:10.1016/0006-8993(85)91047-9 · Cited by 390
CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.
Stuart, P. M., Griffith, T. S., Usui, N., Pepose, J., Yu, X., & Ferguson, T. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119173 · Cited by 367 · cited 1×
“CD95L, which is expressed constitutively by cells of the eye (and other immune-privileged tissues), is partially responsible for acceptance of orthotopic corneal allografts, and for making the cornea and retinal pigment epithelium immune-privileged tissue”
Background
Research works printed but not linked: 5
- Haskova, Z., Arancibia-Carcamo, C. V., Christianson, G. J., Roopenian, D. C. & Ksander, B. R. in Uveitis in the Third Millenium (eds Dodds, E. M. & Couto, C. A.) 7–10 (Elsevier Science, Amsterdam, 2000).
- Sano, Y., Ksander, B. R. & Streilein, J. W. Fate of orthotopic corneal allografts in eyes that cannot support ACAID induction. Invest. Ophthalmol. Vis. Sci. 36, 2176–2185 (1995). This paper shows how immune privilege in the eye is disrupted by experimental manipulations of the cornea.
- Bora, H. S. et al. in Advances in Ocular Imunolology (eds Nussenblatt, R. B., Whitcup, S. M., Caspi, R. R. & Gery, I.) 83–86 (Amsterdam, Elsevier, 1994).
- Hori, J. & Streilein, J. W. Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice. Invest. Ophthalmol. Vis. Sci. 42, 720–726 (2001).
- Ishida, K., Panjwani, N., Cao, Z. & Streilein, J. W. Participation of pigment epithelium in ocular immune privilege. 3. Galectin-1 contributes to immunosuppressive properties of retinal pigment epithelium. Ocular Immun. Inflamm. (in the press).
Cited by
The retina as a window to the brain—from eye research to CNS disorders
London, A., Benhar, I., & Schwartz, M. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.227 · Cited by 1,403
The Spleen in Local and Systemic Regulation of Immunity
Bronte, V., & Pittet, M. J. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.010 · Cited by 1,064
“Antigen inoculation in these immune privileged sites elicits a systemic immune response characterized by the induction of antigen-specific antibodies, failure tomount cellmediated immunity, and allograft acceptance (Streilein, 2003).”
BackgroundMechanisms of Age-Related Macular Degeneration
Ambati, J., & Fowler, B. J. (2012) · Neuron · doi:10.1016/j.neuron.2012.06.018 · Cited by 1,021
Hauswirth, W. W., Aleman, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S. B., Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.107 · Cited by 954
“In addition, the relative immune privilege of posterior ocular spaces is well appreciated (Streilein, 2003) and may serve to further limit any potential immune response to subretinal rAAV2 vector.”
Shechter, R., Miller, O., Yovel, G., Rosenzweig, N., London, A., Ruckh, J., Kim, K.-W., Klein, E., Kalchenko, V., Bendel, P., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.012 · Cited by 683
“The CP also expressed Vip and Thbs1, previously shown to promote immune deviation in immune-privileged sites (Figure 7F; Streilein, 2003).”
TFOS DEWS II pain and sensation report
Belmonte, C., Nichols, J. J., Cox, S. M., Brock, J. A., Begley, C. G., Bereiter, D. A., Dartt, D. A., Galor, A., Hamrah, P., Ivanusic, J. J., et al. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2017.05.002 · Cited by 660
“As a tissue in continuous contact with the outside world, the cornea has evolved as an immune privileged site in order to maintain transparency and preserve vision [145].”
AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer
Costa Verdera, H., Kuranda, K., & Mingozzi, F. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2019.12.010 · Cited by 641
“The eye is a highly compartmentalized organ whose local environment is anatomically isolated from the peripheral immunity by the blood-ocular vasculature, and by the absence of lymphatic vessels.(120,121) Therefore, in the context of gene transfer, the eye has been long thought to be at lower risk for activating innat…”
BackgroundDICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88
Tarallo, V., Hirano, Y., Gelfand, B. D., Dridi, S., Kerur, N., Kim, Y., Cho, W. G., Kaneko, H., Fowler, B. J., Bogdanovich, S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.036 · Cited by 592
“Although the retina is exceptional for its immune privilege (Streilein, 2003), insults mediated by innate immune sensors can result in profound inflammation.”
Injection of Cultured Cells with a ROCK Inhibitor for Bullous Keratopathy
Kinoshita, S., Koizumi, N., Ueno, M., Okumura, N., Imai, K., Tanaka, H., Yamamoto, Y., Nakamura, T., Inatomi, T., Bush, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1712770 · Cited by 542
See no evil, hear no evil, do no evil: the lessons of immune privilege
Niederkorn, J. Y. (2006) · Nature Immunology · doi:10.1038/ni1328 · Cited by 447
“However, seminal studies over the past 30 years by Streilein and colleague”
BackgroundShechter, R., London, A., & Schwartz, M. (2013) · Nature Reviews Immunology · doi:10.1038/nri3391 · Cited by 403
Lin, H.-H., Faunce, D. E., Stacey, M., Terajewicz, A., Nakamura, T., Zhang-Hoover, J., Kerley, M., Mucenski, M. L., Gordon, S., & Stein-Streilein, J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042307 · Cited by 385
“It is well established in the ACAID literature that the efferent T reg cell is CD8 and antigen specific (30, 38).”
BackgroundCorneal Neovascularization: An Anti-VEGF Therapy Review
Chang, J.-H., Garg, N. K., Lunde, E., Han, K.-Y., Jain, S., & Azar, D. T. (2012) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2012.01.007 · Cited by 381
Tissue-based class control: the other side of tolerance
Matzinger, P., & Kamala, T. (2011) · Nature Reviews Immunology · doi:10.1038/nri2940 · Cited by 343
“It protects itself by a process Streilein called “anterior chamber-associated immune deviation”
BackgroundGelatin-Based Materials in Ocular Tissue Engineering
Rose, J., Pacelli, S., Haj, A., Dua, H., Hopkinson, A., White, L., & Rose, F. (2014) · Materials · doi:10.3390/ma7043106 · Cited by 327
“trauma, burns and infectious disease, often vascularization and inflammation can occur which result in a loss of the transparency and immune privilege of the tissue [102].”
BackgroundPAUS, R., NICKOLOFF, B., & ITO, T. (2005) · Trends in Immunology · doi:10.1016/j.it.2004.09.014 · Cited by 325
Interrelation of immunity and tissue repair or regeneration
Eming, S. A., Hammerschmidt, M., Krieg, T., & Roers, A. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2009.04.009 · Cited by 321
“This anterior chamber-associated-immune deviation (ACAID) [23] involves trafficking of stimulated F4/80+ monocytes from the anterior chamber to the marginal zone of the spleen and the return of immune effector cells to the eye.”
BackgroundCNS Infection and Immune Privilege
Forrester, J. V., McMenamin, P. G., & Dando, S. J. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0070-8 · Cited by 313
Uveitis: A Potentially Blinding Disease
Durrani, O. M., Meads, C. A., & Murray, P. I. (2004) · Ophthalmologica · doi:10.1159/000078612 · Cited by 304
Spontaneous autoimmunity prevented by thymic expression of a single self-antigen
DeVoss, J., Hou, Y., Johannes, K., Lu, W., Liou, G. I., Rinn, J., Chang, H., Caspi, R. R., Fong, L., & Anderson, M. S. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061864 · Cited by 275
“It is possible that we may have obtained this result because we focused on a site that has been described as immunologically privileged (28).”
BackgroundNonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision
Cursiefen, C., Chen, L., Saint-Geniez, M., Hamrah, P., Jin, Y., Rashid, S., Pytowski, B., Persaud, K., Wu, Y., Streilein, J. W., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506112103 · Cited by 262
Self-citationZhou, R., & Caspi, R. R. (2010) · F1000 Biology Reports · doi:10.3410/b2-3 · Cited by 259
“that have recovered fromexperimental autoimmuneuveitis (EAU) contain regulatory activity, whose generation is dependent on the presence of eye [7-9].”
BackgroundTaylor, A. W. (2009) · Eye · doi:10.1038/eye.2008.382 · Cited by 253
Hajishengallis, G., & Korostoff, J. M. (2017) · Periodontology 2000 · doi:10.1111/prd.12181 · Cited by 241
“the brain and the eye) have built-in mechanisms to promote the appropriate class of immune response that can potentially protect the tissue against infection without destructive inflammation (172, 197, 264).”
BackgroundBucher, K., Rodríguez-Bocanegra, E., Dauletbekov, D., & Fischer, M. D. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100915 · Cited by 242
The Schlemm’s canal is a VEGF-C/VEGFR-3–responsive lymphatic-like vessel
Aspelund, A., Tammela, T., Antila, S., Nurmi, H., Leppänen, V.-M., Zarkada, G., Stanczuk, L., Francois, M., Mäkinen, T., Saharinen, P., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75395 · Cited by 235
“The SC shares striking structural and functional similarities with lymphatic vessels: it forms a blind-ended tube that does not contain blood, but transports AH and antigen-presenting cells into venous circulation (1, 15, 16).”
Age related macular degeneration and drusen: Neuroinflammation in the retina
Buschini, E., Piras, A., Nuzzi, R., & Vercelli, A. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.05.011 · Cited by 230
Unconventional aqueous humor outflow: A review
Johnson, M., McLaren, J. W., & Overby, D. R. (2017) · Experimental Eye Research · doi:10.1016/j.exer.2016.01.017 · Cited by 221
“Traditionally, the eye has been considered to be devoid of lymphatics (Streilein, 2003).”
London, A., Itskovich, E., Benhar, I., Kalchenko, V., Mack, M., Jung, S., & Schwartz, M. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101202 · Cited by 216
“There, they induce regulatory T cells that can inhibit cellmediated immune responses (Streilein, 2003).”
BackgroundThe Glymphatic System (En)during Inflammation
Mogensen, F. L.-H., Delle, C., & Nedergaard, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147491 · Cited by 210
The impact of sensory neuropathy and inflammation on epithelial wound healing in diabetic corneas
Yu, F.-S. X., Lee, P. S. Y., Yang, L., Gao, N., Zhang, Y., Ljubimov, A. V., Yang, E., Zhou, Q., & Xie, L. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.101039 · Cited by 200
B7-H1-Induced Apoptosis as a Mechanism of Immune Privilege of Corneal Allografts
Hori, J., Wang, M., Miyashita, M., Tanemoto, K., Takahashi, H., Takemori, T., Okumura, K., Yagita, H., & Azuma, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.5928 · Cited by 208
“Eye-associated tolerance, termed ACAID, is one of the major mechanisms for immune privilege of the eyes and maintains acceptance of corneal allografts (10).”
BackgroundInfluentialWIMMERS, S., KARL, M., & STRAUSS, O. (2007) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.12.002 · Cited by 207
“As RPE cells are part of the immune system in the posterior part of the eye (Streilein, 2003; Streilein et al., 2002), the delayed rectifier in the RPE cells may be part of their immune response.”
BackgroundImmune Privilege and Angiogenic Privilege of the Cornea
Cursiefen, C. (2007) · Chemical Immunology and Allergy · doi:10.1159/000099253 · Cited by 204
Toscano, M. A., Commodaro, A. G., Ilarregui, J. M., Bianco, G. A., Liberman, A., Serra, H. M., Hirabayashi, J., Rizzo, L. V., & Rabinovich, G. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.6323 · Cited by 198
“possible role in the establishment of immune privilege (22, 38, 39).”
BackgroundCell death, clearance and immunity in the skeletal muscle
Sciorati, C., Rigamonti, E., Manfredi, A. A., & Rovere-Querini, P. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.171 · Cited by 193
“Early after injury, classically activated macrophages (‘M1’) dominate the picture. Alternatively activated M2 macrophages predominate during resolution phases and regulate the termination of the inflammatory responses. The dynamic M1/M2 transition is increasingly felt to be the key to the homeostasis of the muscle. Re…”
BackgroundInfluentialHLA-Matched Allogeneic iPS Cells-Derived RPE Transplantation for Macular Degeneration
Sugita, S., Mandai, M., Hirami, Y., Takagi, S., Maeda, T., Fujihara, M., Matsuzaki, M., Yamamoto, M., Iseki, K., Hayashi, N., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072217 · Cited by 190
“Moreover, the eye is also known to be a unique organ with a unique environment that has both anti-inflammatory and immunosuppressive mechanisms [16,17].”
BackgroundTime Course of Angiogenesis and Lymphangiogenesis After Brief Corneal Inflammation
Cursiefen, C., Maruyama, K., Jackson, D. G., Streilein, J. W., & Kruse, F. E. (2006) · Cornea · doi:10.1097/01.ico.0000183485.85636.ff · Cited by 190
Self-citationImmune mechanisms in inflammatory and degenerative eye disease
Perez, V. L., & Caspi, R. R. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.04.003 · Cited by 188
Corneal Antigen-Presenting Cells
Hamrah, P., & Dana, M. R. (2007) · Chemical Immunology and Allergy · doi:10.1159/000099254 · Cited by 187
Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases
Bock, F., Maruyama, K., Regenfuss, B., Hos, D., Steven, P., Heindl, L. M., & Cursiefen, C. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.01.001 · Cited by 183
On phagocytes and macular degeneration
Guillonneau, X., Eandi, C. M., Paques, M., Sahel, J.-A., Sapieha, P., & Sennlaub, F. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.06.002 · Cited by 185
“…and adaptive immune responses are dampened or suppressed in these tissues, possibly because they are particularly vulnerable to inflammation induced collateral damage (Streilein, 2003), and the damage to these tissues puts the fitness of the individual at risk (survival or reproductive capacity).”
Background(2008) · PubMed Central · Cited by 183
Robertson, N. J., Brook, F. A., Gardner, R. L., Cobbold, S. P., Waldmann, H., & Fairchild, P. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710265105 · Cited by 183
“TGF- 2, known to be strongly implicated in acquired immune privilege in the eye (23), was expressed upon differentiation of ES cells into EB in vitro, as described (24) and was further up-regulated after their long-term survival in vivo (Fig.”
BackgroundEffects of inflammation on stem cells: together they strive?
Kizil, C., Kyritsis, N., & Brand, M. (2015) · EMBO reports · doi:10.15252/embr.201439702 · Cited by 178
“For instance, TNF-a was shown to impair repair in liver [111], muscle [112,113] and nervous system [114,115].”
Bacterial endophthalmitis: Therapeutic challenges and host–pathogen interactions
CALLEGAN, M., GILMORE, M., GREGORY, M., RAMADAN, R., WISKUR, B., MOYER, A., HUNT, J., & NOVOSAD, B. (2007) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.12.001 · Cited by 177
“) are involved in creating the immunosuppressive environment within the eye (Streilein, 2003).”
BackgroundEndocrine side effects of cancer immunotherapy
Cukier, P., Santini, F. C., Scaranti, M., & Hoff, A. O. (2017) · Endocrine-Related Cancer · doi:10.1530/erc-17-0358 · Cited by 177
Immunological homeostasis of the eye
Mochizuki, M., Sugita, S., & Kamoi, K. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.10.002 · Cited by 175
“…from the iris, ciliary body, or retina of B57BL/6 mice were co-cultured with bystander T cells in the presence of anti-CD3 antibody (Sugita and Streilein, 2003), T-cell activationwas significantly suppressed, indicating that all ocular PE cells are capable of suppressing the activation of…”
BackgroundInfluentialDrug delivery systems for CRISPR-based genome editors
Madigan, V., Zhang, F., & Dahlman, J. E. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00762-x · Cited by 172
Ocular Immune Privilege and Transplantation
Taylor, A. W. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00037 · Cited by 171
Limiting angiogenesis to modulate scar formation
Korntner, S., Lehner, C., Gehwolf, R., Wagner, A., Grütz, M., Kunkel, N., Tempfer, H., & Traweger, A. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.02.010 · Cited by 172
Immune privilege in corneal transplantation
Hori, J., Yamaguchi, T., Keino, H., Hamrah, P., & Maruyama, K. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.04.002 · Cited by 166
Immune Privilege and Eye-Derived T-Regulatory Cells
Keino, H., Horie, S., & Sugita, S. (2018) · Journal of Immunology Research · doi:10.1155/2018/1679197 · Cited by 163
“Both ocular resident mesenchymal cells and peripheral tolerance of ACAID actively contribute to the regulation of immune responses via the generation of Tregs.”
BackgroundInfluentialThrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes
Cursiefen, C., Maruyama, K., Bock, F., Saban, D., Sadrai, Z., Lawler, J., Dana, R., & Masli, S. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20092277 · Cited by 160
“This may be related to the fact that lymphatic vessels (in contrast to blood vessels) do not compromise corneal transparency, an evolutionarily highly conserved quality (Streilein, 2003).”
BackgroundThe critical role of the conjunctiva in glaucoma filtration surgery
Yu, D., Morgan, W. H., Sun, X., Su, E., Cringle, S. J., Yu, P. K., House, P., Guo, W., & Yu, X. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.06.004 · Cited by 154
“Stability of the normal aqueous flow is maintained by remarkable immune privilege conditions in the intraocular environment (Streilein, 2003).”
Yiu, G., Chung, S. H., Mollhoff, I. N., Nguyen, U. T., Thomasy, S. M., Yoo, J., Taraborelli, D., & Noronha, G. (2020) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2020.01.002 · Cited by 153
“Compared to systemic delivery, AAV in the subretinal space elicits a reduced immune response compared to systemic delivery, similar to the anterior chamber-associated immune deviation (ACAID) that enables corneal transplantation without immunosuppression.(21,22) However, the technique is more difficult and subject to…”
BackgroundOrganoid technology for retinal repair
Llonch, S., Carido, M., & Ader, M. (2017) · Developmental Biology · doi:10.1016/j.ydbio.2017.09.028 · Cited by 164
“Though the retina has an immune-privileged status (Streilein, 2003), inflammation might have important influence on transplant survival and maturation, particularly when using human photoreceptors in preclinical animal models.”
BackgroundAAV8 Can Induce Innate and Adaptive Immune Response in the Primate Eye
Reichel, F. F., Dauletbekov, D. L., Klein, R., Peters, T., Ochakovski, G. A., Seitz, I. P., Wilhelm, B., Ueffing, M., Biel, M., Wissinger, B., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.08.018 · Cited by 145
Where should siRNAs go: applicable organs for siRNA drugs
Ahn, I., Kang, C. S., & Han, J. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00998-y · Cited by 171
Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege.
Ito, T., Ito, N., Saathoff, M., Stampachiacchiere, B., Bettermann, A., Bulfone-Paus, S., Takigawa, M., Nickoloff, B., & Paus, R. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23927.x · Cited by 146
Triggering of TLR3 by polyI:C in human corneal epithelial cells to induce inflammatory cytokines
Ueta, M., Hamuro, J., Kiyono, H., & Kinoshita, S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.196 · Cited by 148
The privileged immunity of immune privileged organs: the case of the eye
Benhar, I., London, A., & Schwartz, M. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00296 · Cited by 142
“As vision is crucial for survival, it is understandable why the eye would be particularly protected from these risks (Streilein, 2003a).”
BackgroundInfluentialImmunological Characteristics of Amniotic Epithelium
Hori, J., Wang, M., Kamiya, K., Takahashi, H., & Sakuragawa, N. (2006) · Cornea · doi:10.1097/01.ico.0000247214.31757.5c · Cited by 143
Contact lens-related corneal infection: Intrinsic resistance and its compromise
Fleiszig, S. M. J., Kroken, A. R., Nieto, V., Grosser, M. R., Wan, S. J., Metruccio, M. M. E., & Evans, D. J. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.100804 · Cited by 158
“This incredible biological achievement also relies on the immune-privileged nature of the cornea to minimize potentially damaging inflammation from unwanted immune responses to environmental antigens (microbial or otherwise) (Hamrah and Dana, 2007; Niederkorn, 2011; Streilein, 2003).”
BackgroundConcise Review: Workshop Review: Understanding and Assessing the Risks of Stem Cell-Based Therapies
Heslop, J. A., Hammond, T. G., Santeramo, I., Piella, A. T., Hopp, I., Zhou, J., Baty, R. S., Graziano, E. I., Marco, B. P., Caron, A., et al. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0110 · Cited by 151
Bronkhorst, I. H. G., Vu, T. H. K., Jordanova, E. S., Luyten, G. P. M., van der Burg, S. H., & Jager, M. J. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-9280 · Cited by 143
“This may be related to the immunoregulatory influence of the intraocular microenvironment.(8) For instance, similar to the situation in experimental anterior chamber associated immune deviation (ACAID), human ocular tumor cells may escape from the eye and induce regulatory T cells (Tregs) that subsequently suppress th…”
ResultAnatomy and Immunology of the Ocular Surface
Knop, E., & Knop, N. (2007) · KARGER eBooks · doi:10.1159/000099252 · Cited by 139
Impaired angiopoietin/Tie2 signaling compromises Schlemm’s canal integrity and induces glaucoma
Kim, J., Park, D. Y., Bae, H., Park, D. Y., Kim, D., Lee, C., Song, S., Chung, T.-Y., Lim, D. H., Kubota, Y., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94668 · Cited by 141
“Similar to the thoracic duct, which drains lymph into the subclavian vein through the lymphovenous valve (11), the SC constitutes a blind-ended tube that transfers AH and antigen-presenting cells to the systemic circulation through the episcleral vein (12, 13).”
BackgroundLimbal stem cells: identity, developmental origin, and therapeutic potential
González, G., Sasamoto, Y., Ksander, B. R., Frank, M. H., & Frank, N. Y. (2017) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.303 · Cited by 142
“The central cornea is a well-known and established “immune privileged” tissue that allows the survival of fully allogeneic corneal transplants in low-risk recipient patients (115).”
Wieghofer, P., Hagemeyer, N., Sankowski, R., Schlecht, A., Staszewski, O., Amann, L., Gruber, M., Koch, J., Hausmann, A., Zhang, P., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020105123 · Cited by 141
“Several compartments of the eye reside behind specialized blood–tissue barriers that are formed by tight junctions between endothelial cells and other structural specializations, such as tight junctions among ocular pigment epithelial cells (Streilein, 2003).”
Schwartz, M., & Shechter, R. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.31 · Cited by 135
Palmer, D. C., Chan, C., Gattinoni, L., Wrzesinski, C., Paulos, C. M., Hinrichs, C. S., Powell, D. J., Klebanoff, C. A., Finkelstein, S. E., Fariss, R. N., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710929105 · Cited by 132
“This lack of CD8 T cell reactivity may be in part because of the relatively low MHC class I expression on melanin-containing tissues, poor antigen-MHC affinity (22, 23), antigen-presenting cell inactivation (15), or deficiencies in antigen processing (24).”
BackgroundResultInfluentialLet There Be Light: Gene and Cell Therapy for Blindness
Dalkara, D., Goureau, O., Marazova, K., & Sahel, J. (2016) · Human Gene Therapy · doi:10.1089/hum.2015.147 · Cited by 146
Alloimmunity and Tolerance in Corneal Transplantation
Amouzegar, A., Chauhan, S. K., & Dana, R. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600251 · Cited by 141
“ACAID is a form of immune tolerance to alloantigens placed in the anterior chamber of the eye that results in downregulation of Ag-specific delayed-type hypersensitivity (DTH) response while promoting humoral immunity and production of noncomplement-fixing Abs (16).”
BackgroundAllergic Conjunctivitis-induced Retinal Inflammation Promotes Myopia Progression
Wei, C., Kung, Y.-J., Chen, C. S., Chang, C.-Y., Lin, C.-J., Tien, P., Chang, H., Chen, H.-J., Huang, Y.-S., Lin, H.-J., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.01.024 · Cited by 130
“In immune-privileged tissues, such as the placenta, cornea, and testis, CD55 is overexpressed and lowers inflammatory responses in these tissues (Streilein, 2003; Sohn et al., 2007).”
BackgroundXenotransplantation-The Future of Corneal Transplantation?
Hara, H., & Cooper, D. K. C. (2010) · Cornea · doi:10.1097/ico.0b013e3181f237ef · Cited by 128
“Immune privilege is well documented in relation to the eye, brain, ovary, testis, adrenal cortex, and certain solid tumors and in the fetus in pregnancy.(72) It is thought to be an evolutionary adaptation to protect vital structures from the potentially damaging effects of an inflammatory immune response.”
BackgroundInnate Immune Response in Retinal Homeostasis and Inflammatory Disorders
Murakami, Y., Ishikawa, K., Nakao, S., & Sonoda, K.-H. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.100778 · Cited by 125
In vivo gene regulation using tetracycline-regulatable systems
Stieger, K., Belbellaa, B., Guiner, C. L., Moullier, P., & Rolling, F. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.12.016 · Cited by 151
“2) [17,18] is consistent with the fact that, unlike skeletal muscle, the retina is likely an immune-privilege site [136].”
BackgroundHYALOCYTES: Essential Cells of the Vitreous Cavity in Vitreoretinal Pathophysiology?
Sakamoto, T., & Ishibashi, T. (2011) · Retina · doi:10.1097/iae.0b013e3181facfa9 · Cited by 121
“Anterior chamber–associated immune deviation can be induced by antigen injection for peripheral tolerance to that antigen.(40) It is demonstrated that anterior chamber–associated immune deviation is induced by bone marrow–derived antigen-presenting cells, which are positive for F4/80, a marker of a wide range of matur…”
BackgroundPathogenesis of herpes stromal keratitis – A focus on corneal neovascularization
Giménez, F., Suryawanshi, A. S., & Rouse, B. T. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.07.002 · Cited by 125
“This topic has received several excellent reviews and will not be further discussed (Niederkorn, 2006; Streilein, 2003).”
BackgroundCharacterization of Vitamin D Production by Human Ocular Barrier Cells
Al-Salem, J. A., Patel, D., Susarla, R., Coca‐Prados, M., Bland, R., Walker, E. A., Rauz, S., & Wallace, G. R. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13019 · Cited by 130
Advances in Pancreatic Islet Transplantation Sites for the Treatment of Diabetes
Cayabyab, F., Nih, L. R., & Yoshihara, E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.732431 · Cited by 133
Retinal Pigment Epithelium-Derived CTLA-2α Induces TGFβ-Producing T Regulatory Cells,
Sugita, S., Horie, S., Nakamura, O., Futagami, Y., Takase, H., Keino, H., Aburatani, H., Katunuma, N., Ishidoh, K., Yamamoto, Y., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7525 · Cited by 126
“These organs and tissues are considered immune-privileged sites (2).”
BackgroundCorneal Transplantation and Immune Privilege
Niederkorn, J. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2012.737877 · Cited by 116
Meningeal Lymphatics: From Anatomy to Central Nervous System Immune Surveillance
Papadopoulos, Z., Herz, J., & Kipnis, J. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900838 · Cited by 117
Immune escape mechanisms of intraocular tumors
Niederkorn, J. Y. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.06.002 · Cited by 121
“The hallmarks of ACAID are the antigen-specific down-regulation of DTH and CTL responses, with the preservation of antibody production (Niederkorn, 2006b, 2007; Streilein, 2003).”
BackgroundLack of T Cell Response to iPSC-Derived Retinal Pigment Epithelial Cells from HLA Homozygous Donors
Sugita, S., Iwasaki, Y., Makabe, K., Kimura, T., Futagami, T., Suegami, S., & Takahashi, M. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.08.011 · Cited by 115
“RPE cells have both proliferative and anti-proliferative effects on T cells, and these effects are regulated by cytokines (Streilein, 2003; Sugita, 2009).”
BackgroundEndogenous modulators of inflammatory cell recruitment
Hajishengallis, G., & Chavakis, T. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.08.003 · Cited by 124
Compartmentalized ocular lymphatic system mediates eye–brain immunity
Yin, X., Zhang, S., Lee, J. H., Dong, H., Mourgkos, G., Terwilliger, G., Kraus, A., Geraldo, L. H., Poulet, M., Fischer, S., et al. (2024) · Nature · doi:10.1038/s41586-024-07130-8 · Cited by 108
“Previously, both the eye and brain, which are devoid of traditional lymphatic vessels, were considered immune-privileged tissues because foreign tissue grafts can survive after implantation 36,37 .”
Inhibition of Inflammatory Lymphangiogenesis by Integrin α5 Blockade
Dietrich-Ntoukas, T., Onderka, J., Bock, F., Kruse, F. E., Vossmeyer, D., Stragies, R., Zahn, G., & Cursiefen, C. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060896 · Cited by 114
Immunology of AAV-Mediated Gene Transfer in the Eye
Willett, K., & Bennett, J. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00261 · Cited by 105
“This response is mediated by a population of antigen-specific regulatory T cells (Treg) that are elaborated in a multi-stage process involving the eye as well as the spleen, and these mechanisms are thoroughly reviewed by Streilein (14).”
BackgroundIweala, O. I., & Nagler‐Anderson, C. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00431.x · Cited by 120
Bouquet, C., Vignal Clermont, C., Galy, A., Fitoussi, S., Blouin, L., Munk, M. R., Valero, S., Meunier, S., Katz, B., Sahel, J. A., et al. (2019) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2018.6902 · Cited by 104
Immune Privilege of Corneal Allografts
Niederkorn, J. Y., & Larkin, F. (2010) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2010.486100 · Cited by 109
“Various categories of tumor and tissue allograft s experience prolonged and sometimes, permanent survival when transplanted into the AC, yet are promptly rejected if transplanted to other body sites [44, 45 ] . Since the orthotopic corneal allograft is in direct juxtaposition to the AC, it benefi ts from its immune pr…”
BackgroundNegative regulators that mediate ocular immune privilege
Taylor, A. W., & Ng, T. F. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir0817-337r · Cited by 104
Immune regulation and the eye.
Stein-Streilein, J. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.08.002 · Cited by 99
Müller Glia in Retinal Innate Immunity: A Perspective on Their Roles in Endophthalmitis
Kumar, A., Pandey, R. K., Miller, L. J., Singh, P. K., & Kanwar, M. (2013) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2013006618 · Cited by 99
CD4+ T-Cell–Mediated Mechanisms of Corneal Allograft Rejection: Role of Fas-Induced Apoptosis
Hegde, S., Beauregard, C., Mayhew, E. S., & Niederkorn, J. Y. (2004) · Transplantation · doi:10.1097/01.tp.0000147196.79546.69 · Cited by 98
“The anterior chamber and the cornea that borders it are both considered immune-privileged sites (1, 2).”
BackgroundRole of ocular pigment epithelial cells in immune privilege
Sugita, S. (2009) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-009-0030-0 · Cited by 99
“To avoid these consequences of intraocular inflammation, the eye expresses an extensive array of mechanisms by which innate and adaptive immune effectors can be regulated, and even silenced (Streilein 2003).”
BackgroundToxoplasma gondii Pneumonia in Immunocompetent Subjects: Case Report and Review
Leal, F. E., Cavazzana, C. L., de Andrade, H. F., Galisteo, A. J., de Mendonça, J. S., & Kallas, E. G. (2007) · Clinical Infectious Diseases · doi:10.1086/511871 · Cited by 97
“In the CNS and in the eye, 2 immune privileged sites where antibody and complement levels are low [9, 10], ongoing tachyzoite destruction can occur, although resolution of infection has occurred in other tissues.”
Background
Metadata
- Authors
- Streilein, J. W.
- Affiliations
- Harvard University (US)
- Corresponding author
- Streilein, J. Wayne
- Venue
- Nature Reviews Immunology
- Published
- 2003-11
- Volume
- 3
- Issue
- 11
- Pages
- 879-889
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2166550261
- Cited by
- 807
- References
- 125
- Citations by year
- 2026: 33 · 2025: 33 · 2024: 40 · 2023: 31 · 2022: 43 · 2021: 54 · 2020: 46 · 2019: 31 · 2018: 33 · 2017: 44 · 2016: 39 · 2015: 34 · 2014: 28 · 2013: 31 · 2012: 37
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Keywords
- ocular immune privilege, eye, intraocular inflammation, vision loss, autoimmune eye disease, corneal transplantation, allograft acceptance, corneal immunology
- MeSH terms
- Animals, Autoimmune Diseases, Eye, Eye Diseases, Humans, Immunity, Inflammation, Transplantation, Homologous
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.